Did FDA Do Right by Cutting Acetaminophen Dose in Rx Products? - Anesthesiology News


Clinicians striving to provide patients with pain relief, without risking toxicity, received some support from federal officials in January, when the FDA recommended limiting the dose of acetaminophen to 325 mg in combined prescription products.

Charles Seifert, PharmD, FCCP, BCPS, described it as a thoughtful approach. “If you reduce the amount of acetaminophen in those products, that’s a really nice middle ground, if you will,” said Dr. Seifert, professor of pharmacy practice in the School of Pharmacy at Texas Tech University Health Sciences Center in Lubbock. “Now you can still get them as Schedule III. But you hope that, as you increase the narcotic component, the acetaminophen doesn’t exceed 4 g a day.” ...

Read the full story


Related Stories

TTUHSC School of Nursing to Celebrate New YWCA Location

Community members in central Lubbock now have access to health care services and prenatal programs at one location inside the YWCA.

A Rite of Passage for Next Generation of Physicians

Students in TTUHSC's School of Medicine Class of 2028 received their first white coat and pledged their commitment to the medical profession at the White Coat Ceremony Friday (July 26) at the Buddy Holly Hall of Performing Arts and Sciences.

How Does Your Garden Grow?

As spring approaches, some people’s thoughts turn to gardening. Whether it’s a flower garden they desire or a vegetable garden want to have, they begin planning what they’ll plant and what they need to do to ensure a successful garden.

Recent Stories

Education

Alumni Spotlight: Sister Duo Offers Local, Personalized Allied Health Services

Abagale (Abby) Chapman, OT (2014), and Hannah Cowden, SLP (2017), are sisters working together to help children in Lubbock and the surrounding areas become the greatest version of themselves.

Education

TTUHSC Faculty Receive Chancellor’s Council Distinguished Teaching and Research Awards

Recognizing academic excellence, the honors are the most prestigious awards granted to faculty throughout the TTU System.

Research

TTUHSC Researchers Developing Lupus Treatment

Jon McCord, Ph.D., a recent postdoc at the TTUHSC School of Medicine, and Bryan Sutton, Ph.D., from TTUHSC’s Department of Cell Physiology and Molecular Biophysics, study a mutation in a specific protein found in lupus patients. Together, they aim to become the force behind this new, patent pending therapy.